4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-24-115694
Options or other derivatives
- Chief Executive Officer acquired 455,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2024-10-16 | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | D: show line 1 in the form | |||||
| Kulkarni Samarth Chief Executive Officer | 2024-10-16 | Grant or award · Restricted Stock Units | +400,000 | 400,000 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…